Non-viral gene transfection technologies for genetic engineering of stem cells.

[1]  Y. Tabata,et al.  Expression profile of plasmid DNA by spermine derivatives of pullulan with different extents of spermine introduced. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Y. Tabata,et al.  Transplantation of genetically engineered mesenchymal stem cells improves cardiac function in rats with myocardial infarction: benefit of a novel nonviral vector, cationized dextran. , 2006, Tissue engineering.

[3]  Y. Tabata,et al.  A reverse transfection technology to genetically engineer adult stem cells. , 2006, Tissue engineering.

[4]  Y. Tabata,et al.  Gene Transfer Using Nonviral Delivery Systems , 2006, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[5]  A. Parker,et al.  Delivery of RNA Interference , 2006, Cell cycle.

[6]  Y. Tabata,et al.  Liver targeting of plasmid DNA with a cationized pullulan for tumor suppression. , 2006, Journal of nanoscience and nanotechnology.

[7]  Y. Kaneda,et al.  Non‐viral vectors for cancer therapy , 2006, Cancer science.

[8]  Y. Tabata,et al.  Cationized gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma , 2006, Cancer science.

[9]  Stephen P. Fox,et al.  Delivery strategies for siRNA-mediated gene silencing. , 2006, Current drug delivery.

[10]  Yasuhiko Tabata,et al.  Enhanced ectopic bone formation using a combination of plasmid DNA impregnation into 3-D scaffold and bioreactor perfusion culture. , 2006, Biomaterials.

[11]  I. Khalil,et al.  Uptake Pathways and Subsequent Intracellular Trafficking in Nonviral Gene Delivery , 2006, Pharmacological Reviews.

[12]  S. Kawakami,et al.  Enhanced gene expression in lung by a stabilized lipoplex using sodium chloride for complex formation , 2005, The journal of gene medicine.

[13]  Y. Tabata,et al.  Ultrasound enhances in vivo tumor expression of plasmid DNA by PEG-introduced cationized dextran. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[14]  A. Maitra.  Calcium phosphate nanoparticles: second-generation nonviral vectors in gene therapy , 2005, Expert review of molecular diagnostics.

[15]  Ryuichi Morishita,et al.  Gene transfer into adult rat spinal cord using naked plasmid DNA and ultrasound microbubbles , 2005, The journal of gene medicine.

[16]  Y. Tabata,et al.  Impregnation of plasmid DNA into three-dimensional scaffolds and medium perfusion enhance in vitro DNA expression of mesenchymal stem cells. , 2005, Tissue engineering.

[17]  Y. Tabata,et al.  Perfusion culture enhances osteogenic differentiation of rat mesenchymal stem cells in collagen sponge reinforced with poly(glycolic Acid) fiber. , 2005, Tissue engineering.

[18]  T. Allen,et al.  Ligand-targeted liposomes for cancer treatment. , 2005, Current drug delivery.

[19]  Y. Kaneda,et al.  Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector. , 2005, Biochemical and biophysical research communications.

[20]  Yasufumi Kaneda,et al.  Rad51 siRNA delivered by HVJ envelope vector enhances the anti‐cancer effect of cisplatin , 2005, The journal of gene medicine.

[21]  Y. Tabata,et al.  Delivery of plasmid DNA expressing small interference RNA for TGF-beta type II receptor by cationized gelatin to prevent interstitial renal fibrosis. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Y. Kaneda,et al.  Biocompatible polymer enhances the in vitro and in vivo transfection efficiency of HVJ envelope vector , 2005, The journal of gene medicine.

[23]  Fischer L Tan,et al.  Application of RNAi to cancer research and therapy. , 2005, Frontiers in bioscience : a journal and virtual library.

[24]  J. Miyake,et al.  On-chip transfection of PC12 cells based on the rational understanding of the role of ECM molecules: efficient, non-viral transfection of PC12 cells using collagen IV , 2005, Neuroscience Letters.

[25]  Y. Takakura,et al.  The hydrodynamics-based procedure for controlling the pharmacokinetics of gene medicines at whole body, organ and cellular levels. , 2005, Advanced drug delivery reviews.

[26]  M. Mano,et al.  Cationic liposomes for gene delivery , 2005, Expert opinion on drug delivery.

[27]  V. Torchilin.  Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[28]  Ryuichi Morishita,et al.  An efficient gene transfer method mediated by ultrasound and microbubbles into the kidney , 2005, The journal of gene medicine.

[29]  J. Gehl,et al.  Electric pulse-mediated gene delivery to various animal tissues. , 2005, Advances in genetics.

[30]  Jeremy C Simpson,et al.  Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[31]  Tetsuro Tanaka,et al.  Intracellular disposition of polysaccharides in rat liver parenchymal and nonparenchymal cells. , 2004, International journal of pharmaceutics.

[32]  D. Wells,et al.  Gene Therapy Progress and Prospects: Electroporation and other physical methods , 2004, Gene Therapy.

[33]  K. Matsumoto,et al.  Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin , 2004, Gene Therapy.

[34]  D. Freyssenet,et al.  In vivo gene electrotransfer into skeletal muscle: effects of plasmid DNA on the occurrence and extent of muscle damage , 2004, The journal of gene medicine.

[35]  Y. Tabata,et al.  Suppression of the Progress of Disseminated Pancreatic Cancer Cells by NK4 Plasmid DNA Released from Cationized Gelatin Microspheres , 2004, Pharmaceutical Research.

[36]  C. Dass.  Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection , 2004, Journal of Molecular Medicine.

[37]  M. Nishikawa,et al.  Restoration of dystrophin expression in mdx mice by intravascular injection of naked DNA containing full-length dystrophin cDNA , 2004, Gene Therapy.

[38]  Y. Tabata,et al.  PEGylation enhances tumor targeting of plasmid DNA by an artificial cationized protein with repeated RGD sequences, Pronectin. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[39]  Robert J. Lee,et al.  Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptor. , 2004, Advanced drug delivery reviews.

[40]  Masato Miyake,et al.  Transfection microarray of human mesenchymal stem cells and on-chip siRNA gene knockdown. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[41]  Kazuo Maruyama,et al.  Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system. , 2004, Biochemistry.

[42]  D. Stolz,et al.  Hydroporation as the mechanism of hydrodynamic delivery , 2004, Gene Therapy.

[43]  C. Lehr,et al.  Lectin-mediated drug targeting: history and applications. , 2004, Advanced drug delivery reviews.

[44]  Daniel Scherman,et al.  Plasmid DNA electrotransfer for intracellular and secreted proteins expression: new methodological developments and applications , 2004, The journal of gene medicine.

[45]  F. Lang,et al.  Clinical Trials of Adenoviruses in Brain Tumors: A Review of Ad-p53 and Oncolytic Adenoviruses , 2003, Journal of Neuro-Oncology.

[46]  G. Molema,et al.  In Vivo Characteristics of Cationic Liposomes as Delivery Vectors for Gene Therapy , 2002, Pharmaceutical Research.

[47]  Y. Tabata,et al.  In Vitro Transfection of Plasmid DNA by Amine Derivatives of Gelatin Accompanied with Ultrasound Irradiation , 2002, Pharmaceutical Research.

[48]  Hamidreza Ghandehari,et al.  Controlled Release of Plasmid DNA from a Genetically Engineered Silk-Elastinlike Hydrogel , 2002, Pharmaceutical Research.

[49]  S. W. Kim,et al.  Systemic Administration of TerplexDNA System: Pharmacokinetics and Gene Expression , 2001, Pharmaceutical Research.

[50]  H. Hamana,et al.  Evaluation of Carboxymethylpullulan as a Novel Carrier for Targeting Immune Tissues , 2001, Pharmaceutical Research.

[51]  S. Kawakami,et al.  In Vivo Gene Delivery to the Liver Using Novel Galactosylated Cationic Liposomes , 2000, Pharmaceutical Research.

[52]  D. Fischer,et al.  A Novel Non-Viral Vector for DNA Delivery Based on Low Molecular Weight, Branched Polyethylenimine: Effect of Molecular Weight on Transfection Efficiency and Cytotoxicity , 1999, Pharmaceutical Research.

[53]  W. Mark Saltzman,et al.  Controlled DNA Delivery Systems , 1999, Pharmaceutical Research.

[54]  Y. Capan,et al.  Preparation and Characterization of Poly (D,L-Lactide-Co-Glycolide) Microspheres for Controlled Release of Poly(L-Lysine) Complexed Plasmid DNA , 1999, Pharmaceutical Research.

[55]  Y. Ikada,et al.  Liver Targeting of Interferon Through Pullulan Conjugation , 1996, Pharmaceutical Research.

[56]  S. W. Kim,et al.  Biodegradable Polyester, Poly[α-(4-Aminobutyl)-l-Glycolic Acid], as a Non-Toxic Gene Carrier , 2004, Pharmaceutical Research.

[57]  R. Schiffelers,et al.  Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. , 2004, Nucleic acids research.

[58]  Y. Tabata,et al.  Local delivery of matrix metalloproteinase gene prevents the onset of renal sclerosis in streptozotocin-induced diabetic mice. , 2003, Tissue engineering.

[59]  J. Blebea,et al.  Clinical gene therapy for nonmalignant disease. , 2003, The American journal of medicine.

[60]  K. Tachibana,et al.  Gene transfer with echo-enhanced contrast agents: comparison between Albunex, Optison, and Levovist in mice--initial results. , 2003, Radiology.

[61]  Russell J Mumper,et al.  Microparticles and nanoparticles as delivery systems for DNA vaccines. , 2003, Critical reviews in therapeutic drug carrier systems.

[62]  M. Hedley.  Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors , 2003, Expert opinion on biological therapy.

[63]  Cristina Pislaru,et al.  Optimization of ultrasound-mediated gene transfer: comparison of contrast agents and ultrasound modalities. , 2003, European heart journal.

[64]  Raffi Bekeredjian,et al.  Ultrasound-Targeted Microbubble Destruction Can Repeatedly Direct Highly Specific Plasmid Expression to the Heart , 2003, Circulation.

[65]  R. Levy,et al.  DNA delivery from an intravascular stent with a denatured collagen-polylactic-polyglycolic acid-controlled release coating: mechanisms of enhanced transfection , 2003, Gene Therapy.

[66]  Raffi Bekeredjian,et al.  Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. , 2003, Journal of the American College of Cardiology.

[67]  S. Simões,et al.  Cationic liposomes for gene delivery: from biophysics to biological applications. , 2003, Current medicinal chemistry.

[68]  Y. Tabata,et al.  In vivo release and gene expression of plasmid DNA by hydrogels of gelatin with different cationization extents. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[69]  J. Gehl,et al.  Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. , 2003, Acta physiologica Scandinavica.

[70]  Y. Tabata,et al.  Ultrasound enhances the transfection of plasmid DNA by non-viral vectors. , 2003, Current pharmaceutical biotechnology.

[71]  Y. Tabata,et al.  Biodegradable gelatin hydrogel potentiates the angiogenic effect of fibroblast growth factor 4 plasmid in rabbit hindlimb ischemia. , 2003, Journal of the American College of Cardiology.

[72]  T. Partridge,et al.  Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damage , 2003, Gene Therapy.

[73]  Y. Tabata,et al.  Hybrid Cell–Gene Therapy for Pulmonary Hypertension Based on Phagocytosing Action of Endothelial Progenitor Cells , 2003, Circulation.

[74]  Kevin E Healy,et al.  Nanoparticulate DNA packaging using terpolymers of poly(lysine-g-(lactide-b-ethylene glycol)). , 2003, Bioconjugate chemistry.

[75]  I. Schmidt-Wolf,et al.  Non-viral and hybrid vectors in human gene therapy: an update. , 2003, Trends in molecular medicine.

[76]  W. Saltzman,et al.  Gene expression and mucosal immune responses after vaginal DNA immunization in mice using a controlled delivery matrix. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[77]  Jae-Hyung Jang,et al.  Controllable delivery of non-viral DNA from porous scaffolds. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[78]  T. Wickham.  Ligand-directed targeting of genes to the site of disease , 2003, Nature Medicine.

[79]  T. Niidome,et al.  Gene Therapy Progress and Prospects: Nonviral vectors , 2002, Gene Therapy.

[80]  Hongzhe Sun,et al.  Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway , 2002, Pharmacological Reviews.

[81]  J. Nalbantoglu,et al.  Ultrasound increases plasmid-mediated gene transfer to dystrophic muscles without collateral damage. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[82]  J. Isner,et al.  Transcutaneous ultrasound augments naked DNA transfection of skeletal muscle. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[83]  M. Simionescu,et al.  Designing of ‘intelligent’ liposomes for efficient delivery of drugs , 2002, Journal of cellular and molecular medicine.

[84]  Daniel Scherman,et al.  In vivo plasmid DNA electrotransfer. , 2002, Current opinion in biotechnology.

[85]  David M Sabatini,et al.  Cell-biological applications of transfected-cell microarrays. , 2002, Trends in cell biology.

[86]  Philip S Low,et al.  Folate-mediated delivery of macromolecular anticancer therapeutic agents. , 2002, Advanced drug delivery reviews.

[87]  J Wang,et al.  Enhanced gene expression in mouse muscle by sustained release of plasmid DNA using PPE-EA as a carrier , 2002, Gene Therapy.

[88]  R. Bartrons,et al.  Single-stranded DNA condensed with poly-L-lysine results in nanometric particles that are significantly smaller, more stable in physiological ionic strength fluids and afford higher efficiency of gene delivery than their double-stranded counterparts. , 2002, Biochimica et biophysica acta.

[89]  T. Tuschl,et al.  Small interfering RNAs: a revolutionary tool for the analysis of gene function and gene therapy. , 2002, Molecular interventions.

[90]  Y. Tabata,et al.  Enhanced expression of plasmid DNA-cationized gelatin complex by ultrasound in murine muscle. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[91]  Y. Tabata,et al.  Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogel degradation. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[92]  Xuebin B. Yang,et al.  Adenoviral BMP-2 gene transfer in mesenchymal stem cells: in vitro and in vivo bone formation on biodegradable polymer scaffolds. , 2002, Biochemical and biophysical research communications.

[93]  Ryuichi Morishita,et al.  Local Delivery of Plasmid DNA Into Rat Carotid Artery Using Ultrasound , 2002, Circulation.

[94]  Y. Taniyama,et al.  Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle , 2002, Gene Therapy.

[95]  Kazunori Kataoka,et al.  Block copolymer micelles for delivery of gene and related compounds. , 2002, Advanced drug delivery reviews.

[96]  J. Nah,et al.  Artery wall binding peptide-poly(ethylene glycol)-grafted-poly(L-lysine)-based gene delivery to artery wall cells. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[97]  Y. Tabata,et al.  Ultrasound Enhancement of In Vitro Transfection of Plasmid DNA by a Cationized Gelatin , 2002, Journal of drug targeting.

[98]  Ernst Wagner,et al.  Overcoming the nuclear barrier: cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[99]  Robert J. Lee,et al.  Folate receptor-targeted liposomes as vectors for therapeutic agents. , 2002, Biotechnology annual review.

[100]  S. Kawakami,et al.  Glycosylated cationic liposomes for cell-selective gene delivery. , 2002, Critical reviews in therapeutic drug carrier systems.

[101]  J Henke,et al.  Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo , 2002, Gene Therapy.

[102]  T Ochiya,et al.  Atelocollagen-based gene transfer in cells allows high-throughput screening of gene functions. , 2001, Biochemical and biophysical research communications.

[103]  M. Hashida,et al.  Cell-specific delivery of genes with glycosylated carriers. , 2001, Advanced drug delivery reviews.

[104]  Y. Shinohara,et al.  Quantitative studies on the nuclear transport of plasmid DNA and gene expression employing nonviral vectors. , 2001, Advanced drug delivery reviews.

[105]  Ű. Langel,et al.  Targeting of cancer-related proteins with PNA oligomers. , 2001, Current cancer drug targets.

[106]  N. Rainov,et al.  Vector delivery methods and targeting strategies for gene therapy of brain tumors. , 2001, Current gene therapy.

[107]  Wenjin Guo,et al.  Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. , 2001, Bioconjugate chemistry.

[108]  D. Kniss,et al.  Three-dimensional cell-scaffold constructs promote efficient gene transfection: implications for cell-based gene therapy. , 2001, Tissue engineering.

[109]  M. Benet,et al.  Stability of PEI-DNA and DOTAP-DNA complexes: effect of alkaline pH, heparin and serum. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[110]  S. Seigneurin-Venin,et al.  Transfection of large plasmids in primary human myoblasts , 2001, Gene Therapy.

[111]  D. Putnam,et al.  Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[112]  E. Gaidamakova,et al.  Molecular vehicle for target-mediated delivery of therapeutics and diagnostics. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[113]  Leaf Huang,et al.  Transfer of full-length Dmd to the diaphragm muscle of Dmd(mdx/mdx) mice through systemic administration of plasmid DNA. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[114]  S. Carotta,et al.  Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo , 2001, The journal of gene medicine.

[115]  E. Wagner,et al.  Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery. , 2001, Bioconjugate chemistry.

[116]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[117]  Leaf Huang,et al.  Nonviral vectors in the new millennium: delivery barriers in gene transfer. , 2001, Human gene therapy.

[118]  D. Sabatini,et al.  Microarrays of cells expressing defined cDNAs , 2001, Nature.

[119]  T. Ochiya,et al.  Biomaterials for gene delivery: atelocollagen-mediated controlled release of molecular medicines. , 2001, Current gene therapy.

[120]  J. Wolff,et al.  Efficient expression of naked dna delivered intraarterially to limb muscles of nonhuman primates. , 2001, Human gene therapy.

[121]  Tetsuro Tanaka,et al.  Evidence for receptor-mediated hepatic uptake of pullulan in rats. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[122]  E. Wagner,et al.  Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application , 2001, Gene Therapy.

[123]  S. Kawakami,et al.  Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice. , 2000, Biochimica et biophysica acta.

[124]  S. Hart,et al.  Adhesion molecules and gene transfer. , 2000, Advanced drug delivery reviews.

[125]  D. Carlo,et al.  Strength of conjugate binding to plasmid DNA affects degradation rate and expression level in vivo. , 2000, Biochimica et biophysica acta.

[126]  W. Zimmermann,et al.  Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. , 2000, Biotechnology and bioengineering.

[127]  R. J. Lee,et al.  Targeted drug delivery via the folate receptor. , 2000, Advanced drug delivery reviews.

[128]  K. Ulbrich,et al.  DNA delivery systems based on complexes of DNA with synthetic polycations and their copolymers. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[129]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[130]  J. Isner,et al.  Stem cell therapy and gene transfer for regeneration , 2000, Gene Therapy.

[131]  A. Mountain,et al.  Gene therapy: the first decade. , 2000, Trends in biotechnology.

[132]  V. Goiffon,et al.  Calcium phosphate transfection of mammalian cultured cells. , 2000, Methods in molecular biology.

[133]  S. Kawakami,et al.  Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes , 2000, Gene Therapy.

[134]  A. Miller,et al.  Cell delivery, intracellular trafficking and expression of an integrin-mediated gene transfer vector in tracheal epithelial cells , 2000, Gene Therapy.

[135]  F. Liu,et al.  Characterization of a targeted gene carrier, lactose-polyethylene glycol-grafted poly-L-lysine and its complex with plasmid DNA. , 1999, Human gene therapy.

[136]  K. Peng,et al.  Viral vector targeting. , 1999, Current opinion in biotechnology.

[137]  D. Mooney,et al.  Controlled delivery of inductive proteins, plasmid DNA and cells from tissue engineering matrices. , 1999, Journal of periodontal research.

[138]  P. Marschall,et al.  Transfer of YACs up to 2.3 Mb intact into human cells with polyethylenimine , 1999, Gene Therapy.

[139]  E. Brambilla,et al.  In vivo delivery to tumors of DNA complexed with linear polyethylenimine. , 1999, Human gene therapy.

[140]  Y. Kaneda,et al.  Gene therapy using HVJ-liposomes: the best of both worlds? , 1999, Molecular medicine today.

[141]  J. Nemunaitis,et al.  Phase I trial of interferon-γ (IFN-γ) retroviral vector administered intratumorally to patients with metastatic melanoma , 1999, Cancer Gene Therapy.

[142]  T. Ochiya,et al.  New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet , 1999, Nature Medicine.

[143]  David J. Mooney,et al.  DNA delivery from polymer matrices for tissue engineering , 1999, Nature Biotechnology.

[144]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[145]  F. Cosset,et al.  Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines. , 1999, Human gene therapy.

[146]  G. Kwon,et al.  Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[147]  J. Behr,et al.  Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway , 1999, Gene Therapy.

[148]  K. Ulbrich,et al.  Novel vectors for gene delivery formed by self-assembly of DNA with poly(L-lysine) grafted with hydrophilic polymers. , 1998, Biochimica et biophysica acta.

[149]  H. K. Lim,et al.  Production of high-titer retroviral vectors and detection of replication-competent retroviruses. , 1998, Molecules and cells.

[150]  M. Nichifor,et al.  Aminated polysaccharides as bile acid sorbents: in vitro study. , 1998, Journal of biomaterials science. Polymer edition.

[151]  E. Unger,et al.  Ultrasound enhances gene expression of liposomal transfection. , 1997, Investigative radiology.

[152]  S. Ferrari,et al.  ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo , 1997, Gene Therapy.

[153]  J. Ruysschaert,et al.  The role of endosome destabilizing activity in the gene transfer process mediated by cationic lipids , 1997, FEBS letters.

[154]  M. Buchberger,et al.  Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery , 1997, Gene Therapy.

[155]  M. Hashida,et al.  Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine). , 1997, Biochemical pharmacology.

[156]  Leaf Huang,et al.  Liposomal gene delivery: A complex package , 1997, Nature Biotechnology.

[157]  Y. Buechler,et al.  Targeting DNA to Cells with Basic Fibroblast Growth Factor (FGF2)* , 1996, The Journal of Biological Chemistry.

[158]  T. Miyata,et al.  Self-assembly of polymer amphiphiles: thermodynamics of complexation between bovine serum albumin and self-aggregate of cholesterol-bearing pullulan , 1996 .

[159]  K. Akiyoshi,et al.  Macromolecular Complexation between Bovine Serum Albumin and the Self-Assembled Hydrogel Nanoparticle of Hydrophobized Polysaccharides , 1996 .

[160]  A. Takayanagi,et al.  Immunogene approach toward cancer therapy using erythrocyte growth factor receptor-mediated gene delivery. , 1996, Cancer gene therapy.

[161]  J. Kuratsu,et al.  High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation. , 1996, Cancer research.

[162]  T. Reynolds,et al.  T–cell mediated rejection of gene–modified HIV–specific cytotoxic T lymphocytes in HIV–infected patients , 1996, Nature Medicine.

[163]  J. C. Perales,et al.  Receptor-mediated gene transfer into macrophages. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[164]  S. Rosenberg,et al.  T Lymphocyte-Directed Gene Therapy for ADA− SCID: Initial Trial Results After 4 Years , 1995, Science.

[165]  A. Miller,et al.  Gene delivery and expression mediated by an integrin-binding peptide. , 1995, Gene therapy.

[166]  T. Meade,et al.  Transfection of folate-polylysine DNA complexes: evidence for lysosomal delivery. , 1995, Bioconjugate chemistry.

[167]  K. Akiyoshi,et al.  STABILIZATION OF INSULIN UPON SUPRAMOLECULAR COMPLEXATION WITH HYDROPHOBIZED POLYSACCHARIDE NANOPARTICLE , 1995 .

[168]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[169]  R. Horn,et al.  Evidence for voltage-dependent S4 movement in sodium channels , 1995, Neuron.

[170]  H. Farhood,et al.  The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. , 1995, Biochimica et biophysica acta.

[171]  H. Klein,et al.  Cellular gene therapy. , 1995, Hematology/oncology clinics of North America.

[172]  K. Akiyoshi,et al.  Self-Assembly of Hydrophobized Polysaccharide. Structure of Hydrogel Nanoparticle and Complexation with Organic Compounds.:Structure of Hydrogel Nanoparticle and Complexation with Organic Compounds , 1995 .

[173]  Shigeru Deguchi,et al.  Self-Assembly of Hydrophobized Polysaccharide , 1995 .

[174]  C. Wu,et al.  Fate of DNA targeted to the liver by asialoglycoprotein receptor-mediated endocytosis in vivo. Prolonged persistence in cytoplasmic vesicles after partial hepatectomy. , 1993, The Journal of biological chemistry.

[175]  Y. Ikada,et al.  Body distribution profile of polysaccharides after intravenous administration , 1993 .

[176]  Y. Okada.  Sendai virus-induced cell fusion. , 1993, Methods in enzymology.

[177]  M. Raffeld,et al.  Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer , 1992, The Journal of experimental medicine.

[178]  M. Cotten,et al.  Transferrin-polycation-DNA complexes: the effect of polycations on the structure of the complex and DNA delivery to cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[179]  P. Felgner,et al.  Cationic liposome-mediated transfection , 1989, Nature.

[180]  T. N. Palmer,et al.  The mechanism of liposome accumulation in infarction. , 1984, Biochimica et biophysica acta.

[181]  A. Jiménez,et al.  Expression of a transposable antibiotic resistance element in Saccharomyces , 1980, Nature.

[182]  A. van der Eb,et al.  A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.